Allovir, Inc. (ALVR) Deferred Income Tax Expense (Benefit) USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Allovir, Inc. quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Allovir, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $200 K +$200 K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-09-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.